Edap Tms (NASDAQ:EDAP) issued its quarterly earnings data on Wednesday. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01), Fidelity Earnings reports. The company had revenue of $11.35 million during the quarter, compared to analysts’ expectations of $13.15 million. Edap Tms had a net margin of 7.61% and a return on equity of 26.86%.
Shares of NASDAQ:EDAP opened at $4.84 on Friday. The firm has a market capitalization of $139.19 million, a PE ratio of 36.92 and a beta of 1.84. The firm’s 50-day moving average is $4.65 and its two-hundred day moving average is $3.65. Edap Tms has a 1 year low of $1.35 and a 1 year high of $5.42.
Several analysts recently issued reports on EDAP shares. Zacks Investment Research upgraded shares of Edap Tms from a “hold” rating to a “buy” rating and set a $5.25 price objective on the stock in a report on Wednesday. ValuEngine lowered shares of Edap Tms from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, HC Wainwright reiterated a “buy” rating and set a $6.50 price target on shares of Edap Tms in a research note on Friday.
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.